New Devyser BRCA NGS study published

Hereditary cancer

Hereditary cancer | September 30, 2022

Check out a recent publication from Capone et al from the University of Florence!

In this study, the Devyser BRCA test was used to analyze 227 patient DNA samples. They concluded that 100% of the expected SNVS and CNVS were detected and that the single-tube PCR-based library preparation format of the kit offers a decrease in processing time as well as a reduced risk of cross-contamination.

Read abstract using this link

Contact an expert at Devyser

If you have a question, feel free to send us a message. One of our team members will get in touch with you as soon as possible.

New Devyser BRCA NGS study published

Contact an expert at Devyser

Devyser announced the launch of next generation chimerism analysis solution, strengthening its offering in post-transplant monitoring

Devyser secures SEK 8.9M five-year tender and strengthens Italian position

Devyser launches the first IVDR compliant NGS assay for thalassemia and sickle cell disease testing

Devyser acquires Swedish company Cybergene AB and strengthens its position in the aneuploidy market

New Devyser BRCA NGS study published

Contact an expert at Devyser

Related Articles

Devyser announced the launch of next generation chimerism analysis solution, strengthening its offering in post-transplant monitoring

Devyser secures SEK 8.9M five-year tender and strengthens Italian position

Devyser launches the first IVDR compliant NGS assay for thalassemia and sickle cell disease testing

Devyser acquires Swedish company Cybergene AB and strengthens its position in the aneuploidy market